CELUCelularity Inc同业对比
Celularity Inc 与SIC 2834 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CELU本股 | $37M#8 | — | — | 1.4x#4 | -51.0%#8 | -58.4%#10 | -230.9%#7 | — | -398.1%#5 | — | — | — |
| MCRB | $42M#1 | — | 1.2x#9 | 53.4x#11 | — | 4088.2%#1 | -11910.1%#12 | 16.5%#1 | -72.9%#4 | — | -75.4%#8 | — |
| SDEV | $42M#2 | — | 0.3x#1 | 4.3x#7 | -6.4%#5 | -8632.9%#16 | -86.3%#5 | -495.7%#13 | -7.0%#1 | — | -91.5%#9 | 11.6%#1 |
| SCYX | $41M#3 | 14.8x#4 | 0.6x#5 | 2.0x#5 | 449.9%#1 | 59.6%#3 | -78.0%#3 | -12.9%#3 | — | 7#1 | -52.1%#4 | — |
| ATNM | $40M#4 | 3.6x#3 | 1.3x#10 | 443.7x#13 | — | 11.4%#6 | -40274.4%#13 | -111.8%#9 | — | — | -22.8%#1 | — |
| VERU | $40M#5 | — | 1.4x#11 | 2.4x#6 | 3.6%#3 | 39.9%#4 | -146.6%#6 | -80.1%#7 | -399.3%#6 | — | -36.3%#2 | 0.0%#2 |
| KPTI | $39M#6 | — | — | 0.3x#1 | 0.6%#4 | -156.5%#12 | -62.1%#2 | — | — | — | -72.2%#7 | — |
| ELAB | $38M#7 | — | 2.3x#13 | 64.2x#12 | — | -24.0%#8 | -1304.4%#11 | -46.3%#6 | — | — | — | — |
| CRVO | $37M#9 | 0.0x#1 | 1.6x#12 | 9.2x#10 | -58.9%#9 | -65.6%#11 | -706.2%#9 | -117.5%#11 | -5165.9%#7 | — | — | — |
| CNTX | $34M#10 | — | 0.9x#7 | — | — | -35.2%#9 | — | -94.6%#8 | — | — | — | — |
| LITS | $34M#11 | — | 0.6x#4 | — | -100.0%#11 | -189.7%#13 | — | -28.1%#5 | — | — | -62.4%#6 | — |
| FLNA | $33M#12 | — | 0.5x#2 | 0.8x#3 | 277.6%#2 | -273.7%#14 | -232.0%#8 | -133.5%#12 | — | — | — | — |
| RMTI | $32M#13 | 267.0x#5 | 0.9x#8 | 0.5x#2 | -31.8%#7 | -1007.1%#15 | -6.8%#1 | -15.1%#4 | -14.0%#3 | 4#3 | — | — |
| BRNS | $31M#14 | — | 0.5x#3 | — | -100.0%#11 | -8.8%#7 | — | -116.4%#10 | — | — | -37.0%#3 | — |
| CPHI | $31M#15 | — | 0.9x#6 | 7.5x#9 | -8.5%#6 | 32.7%#5 | -78.2%#4 | -8.8%#2 | -7.7%#2 | 5#2 | -61.2%#5 | — |
| KYNB | $31M#16 | 0.2x#2 | — | 4.8x#8 | -78.3%#10 | 485.6%#2 | -712.7%#10 | — | — | — | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-09-17。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议